Number needed to treat and cost-effectiveness in the prevention of ventilator-associated pneumonia 英文参考文献.docVIP

Wyncoll and Camporota Critical Care 2012, 16:430 /content/16/3/430 LETTER Number needed to treat and cost-e? ectiveness in the prevention of ventilator-associated pneumonia Duncan Wyncoll* and Luigi Camporota While clinicians continue to rede? ne ventilator-asso- equivalent to an extra 7 days of intensive care unit (ICU) ciated pneumonia (VAP), numerous innovations that stay. What should we consider when assessing the cost- claim to reduce pulmonary microaspiration and its e? ectiveness of VAP prevention? consequences – that is, novel endotrac